Christopher Voigt, PhD is the Daniel I.C. Wang Professor of Advanced Biotechnology in the Biological Engineering Department at MIT and is Co-Director of the Synthetic Biology Center. He is the Editor-in-Chief of ACS Synthetic Biology. He holds joint appointments at the Broad Institute, Lawrence Berkeley National Labs, Korea Advanced Institute of Science & Technology (KAIST), University of California – San Francisco (UCSF), and Imperial College. He received his BSE in Chemical Engineering from the University of Michigan (1998) and PhD in Biophysics from Caltech (2002). He is a founder of Pivot Bio (microbial agricultural products) and Asimov (human cell synthetic biology). He has served on the science advisory boards of DSM, Bolt Threads, SynLogic, Amyris Biotechnologies, Zymergen, Design Therapeutics, Empress Bio, Aanika, General probiotics, Deepbiome Therapautics, Senti Bio, Axcella, and Twist Bioscience. He is a partner at DCVC Bio, Bio-innovation, and Petri. He has been honored with a National Security Science & Engineering Faculty Fellowship (NSSEFF), Bush Fellows Research Study Team (BFRST), Sloan Fellow, Pew Fellow, Packard Fellow, NSF Career Award, Vaughan Lecturer, MIT TR35, and SynBiobeta Entrepreneurial Leadership Award.